Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02944461 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
A Phase 4 study of Acne, sponsored by Derm Research, P.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 3
- Study locations
NCT02944461: Completed Phase 4 study of Acne, sponsored by Derm Research, P.
NCT02944461 is a Phase 4 study of Acne that has completed, run by Derm Research, P. The registered enrollment target is 20 participants, below the 142-participant average among 26 other Acne trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02944461, a Phase 4 study of Acne, has completed, sponsored by Derm Research, P.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk
Primary Outcome
Investigator will evaluate global acne severity using the IGA scale as follows: 1= Clear Skin, 2 = Almost Clear, 3 = Mild Severity, 4 = Severe, 5 = Very Severe
Conditions Studied
Interventions
- DRUG Dapsone 7.5 % gel
Study Locations (3)
California
- Dermatology and Laser Surgery - Sacramento
Kentucky
- DermResearch, PLLC - Louisville
Nevada
- James Q. DelRosso DO, LLC - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-09-11 |
| Phase | Phase 4 |
What the finished NCT02944461 record still lists
NCT02944461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 142-participant average among 26 other Acne trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Dapsone 7.5 % gel is the first listed.
NCT02944461 reports a single indexed study location in California, Kentucky, Nevada.
Frequently Asked Questions
What is clinical trial NCT02944461 about?
NCT02944461 is a clinical study titled "Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris". To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk
What is the current status of trial NCT02944461?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2016-10. Estimated completion is 2017-09-11.
What conditions does trial NCT02944461 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT02944461?
The interventions under investigation include: Dapsone 7.5 % gel (DRUG).
Who is sponsoring clinical trial NCT02944461?
This trial is sponsored by Derm Research, P, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02944461 being conducted?
This trial has 3 study locations across California, Kentucky, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02944461's enrollment target sits among peer trials
20 23rd of 26 higher than 3 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
ACTIVE NOT RECRUITING · Phase 4
-
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
COMPLETED · Phase 4
-
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
COMPLETED · Phase 4
-
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
COMPLETED · Phase 4
-
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
COMPLETED · Phase 4
-
Comparison Study of Topical Acne Regimens
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia